Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants.

Bauer M, Adli M, Bschor T, Pilhatsch M, Pfennig A, Sasse J, Schmid R, Lewitzka U.

Neuropsychobiology. 2010;62(1):36-42. doi: 10.1159/000314308. Epub 2010 May 7. Review.

2.

Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.

Bauer M, Adli M, Baethge C, Berghöfer A, Sasse J, Heinz A, Bschor T.

Can J Psychiatry. 2003 Aug;48(7):440-8. Review.

PMID:
12971013
4.

Efficacy and mechanisms of action of lithium augmentation in refractory major depression.

Bschor T, Bauer M.

Curr Pharm Des. 2006;12(23):2985-92. Review.

PMID:
16918427
5.

Role of lithium augmentation in the management of major depressive disorder.

Bauer M, Adli M, Ricken R, Severus E, Pilhatsch M.

CNS Drugs. 2014 Apr;28(4):331-42. doi: 10.1007/s40263-014-0152-8. Review.

PMID:
24590663
6.

Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.

Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M.

Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S230-4. Review.

PMID:
14677084
7.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
8.
9.

Lithium augmentation therapy in refractory depression-update 2002.

Bauer M, Forsthoff A, Baethge C, Adli M, Berghöfer A, Döpfmer S, Bschor T.

Eur Arch Psychiatry Clin Neurosci. 2003 Jun;253(3):132-9. Review.

PMID:
12904977
10.

Antidepressant augmentation and combinations.

Dording CM.

Psychiatr Clin North Am. 2000 Dec;23(4):743-55. Review.

PMID:
11147245
11.

Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.

Hantouche EG, Akiskal HS, Lancrenon S, Chatenêt-Duchêne L.

J Affect Disord. 2005 Feb;84(2-3):243-9.

PMID:
15708422
12.
13.

How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression.

Bschor T, Berghöfer A, Ströhle A, Kunz D, Adli M, Müller-Oerlinghausen B, Bauer M.

J Clin Psychopharmacol. 2002 Aug;22(4):427-30.

PMID:
12172345
14.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
16.

Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression.

Bschor T, Canata B, Müller-Oerlinghausen B, Bauer M.

J Affect Disord. 2001 May;64(2-3):261-5.

PMID:
11313093
17.

[Combination therapies in antidepressive drug refractory depression--an overview].

Schmauss M, Erfurth A.

Fortschr Neurol Psychiatr. 1996 Oct;64(10):390-402. Review. German.

PMID:
9036099
18.

A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression.

Nelson JC, Baumann P, Delucchi K, Joffe R, Katona C.

J Affect Disord. 2014 Oct;168:269-75. doi: 10.1016/j.jad.2014.05.053. Epub 2014 Jun 2. Review.

PMID:
25069082
19.

[Interest of the use of pindolol in the treatment of depression: review].

Brousse G, Schmitt A, Chereau I, Eschalier A, Dubray C, Llorca PM.

Encephale. 2003 Jul-Aug;29(4 Pt 1):338-50. Review. French.

PMID:
14615704
20.

Lithium versus antidepressants in the long-term treatment of unipolar affective disorder.

Cipriani A, Smith K, Burgess S, Carney S, Goodwin G, Geddes J.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003492. Review.

PMID:
17054174
Items per page

Supplemental Content

Write to the Help Desk